Clinical Trial Update: Ruxolitinib for Cancer Cachexia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is evaluating ruxolitinib for cancer cachexia in patients with stage IV non-small cell lung cancer, and the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Tu Dan | Conditions: Stage IV Non-small Cell Lung Cancer, Cachexia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING